MA41574A1 - Pde9 inhibitors having an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases - Google Patents

Pde9 inhibitors having an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases

Info

Publication number
MA41574A1
MA41574A1 MA41574A MA41574A MA41574A1 MA 41574 A1 MA41574 A1 MA 41574A1 MA 41574 A MA41574 A MA 41574A MA 41574 A MA41574 A MA 41574A MA 41574 A1 MA41574 A1 MA 41574A1
Authority
MA
Morocco
Prior art keywords
backbone
imidazo
treatment
triazinone
pyrazinone
Prior art date
Application number
MA41574A
Other languages
French (fr)
Other versions
MA41574B2 (en
Inventor
Niels Svenstrup
Kate Wen
Yazhou Wang
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Priority claimed from PCT/EP2016/065964 external-priority patent/WO2017005786A1/en
Publication of MA41574A1 publication Critical patent/MA41574A1/en
Publication of MA41574B2 publication Critical patent/MA41574B2/en

Links

Abstract

La présente invention concerne des inhibiteurs de pde9 et leur utilisation pour le traitement de l'hyperplasie bénigne de la prostate et de la drépanocytose.The present invention relates to inhibitors of pde9 and their use for the treatment of benign prostatic hyperplasia and sickle cell disease.

MA41574A 2015-07-07 2016-07-06 Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases MA41574B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201500393 2015-07-07
PCT/EP2016/065964 WO2017005786A1 (en) 2015-07-07 2016-07-06 Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases

Publications (2)

Publication Number Publication Date
MA41574A1 true MA41574A1 (en) 2018-07-31
MA41574B2 MA41574B2 (en) 2021-09-30

Family

ID=63639456

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41574A MA41574B2 (en) 2015-07-07 2016-07-06 Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases

Country Status (1)

Country Link
MA (1) MA41574B2 (en)

Also Published As

Publication number Publication date
MA41574B2 (en) 2021-09-30

Similar Documents

Publication Publication Date Title
TN2017000507A1 (en) Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
MX2022010638A (en) Pde9 inhibitors for treatment of peripheral diseases.
EA201101666A1 (en) 3- [4- (7H-PYRROLO [2,3-d] PYRIMIDIN-4-IL) -1H-PYRAZOL-1-IL] OCTAN-OR GEPTANNITRIL AS JAK-INHIBITORS
MA40755B1 (en) Compositions comprising bacterial strains
MA40754B1 (en) Compositions comprising bacterial strains
MX2020010412A (en) Inhibitors of bruton's tyrosine kinase.
EA201791866A1 (en) BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
CL2018002924A1 (en) Bromodomain Inhibitors
EA201290894A1 (en) AZETIDINE DERIVATIVES OF PIPERIDIN-4-ILA AS JAK1 INHIBITORS
EA201500393A1 (en) BLUTON TYROSINKINASE INHIBITORS
EA201791867A1 (en) BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
EA202091709A1 (en) DNA PC INHIBITORS
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
EA201590850A1 (en) TRICYCLIC CONDENSED TIOPHENE DERIVATIVES AS INHIBITORS JAK
EA201792304A1 (en) COMBINED THERAPY FOR CANCER TREATMENT
BR112018006135A2 (en) fused pyrazole derivatives as kinase inhibitors
EA201990523A1 (en) NEW SELECTIVE JAK1 INHIBITORS AND THEIR APPLICATION
MA38284B1 (en) Inhibitors of 2,3-dihydroimidazol [1,2-c] pyrimidin-5 (1 h) -one-2-lipoprotein-associated phospholipase (lp-pla2)
EA201300871A1 (en) DERIVATIVES (1,2,4) TRIAZOLO [4,3-a] CHINOXALINE AS PHOSPHODYESTERES INHIBITORS
MA38827A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in the treatment of hyperproliferative diseases
MX2019014049A (en) Methods of making and using pde9 inhibitors.
EA202091708A1 (en) DNA PC INHIBITORS
EA202191301A1 (en) COMPOSITION OF TABLETS 2-FLUORO-N-METHYL-4- [7- (QUINOLIN-6-YLMETHYL) IMIDAZO [1,2-b] [1,2,4] TRIAZIN-2-YL] BENZAMIDE
FR3084254B1 (en) LANIFIBRANOR DERIVATIVES
WO2018033941A3 (en) Pharmaceutical compositions of ibrutinib